ABSTRACT
Candida auris is an emerging multi-drug resistant yeast responsible for invasive infections among hospitalized patients. We described a case series of C. auris isolated in the Los Angeles area from an ongoing outbreak. Genomic analysis showed a single Clade III lineage of African origin in all 6 cases since 2019.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by the UCLA Department of Pathology and Laboratory Medicine
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a retrospective analysis and is part of an infection prevention and quality improvement project. The institutional review boards (IRB) approval was waived by the UCLA Office of the Human Research Protection Program.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We are in the process of uploading the WGS data of the C. auris to NCBI.
